Veterinary Microbiome Market Size is valued at USD 6,885.40 Bn in 2023 and is predicted to reach USD 12,060.52 Bn by the year 2034 at a 5.4% CAGR during the forecast period for 2024-2034.
The term veterinary microbiome refers to the community of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in and on animals. These microbial populations play a crucial role in digestion, immunity, and disease prevention, making them essential for maintaining animal health. Veterinary microbiome research aims to understand and regulate these microbial communities to enhance the well-being of companion animals, livestock, and other species. Imbalances in the microbiome have been linked to various common disorders in animals, such as diarrhea, stomach pain, gastric inflammation, arthritis, allergies, and food sensitivities, particularly due to the complex microbial interactions within the gastrointestinal (GI) tract.
Increasing awareness among pet owners and livestock producers highlights the importance of maintaining a balanced microbiome for overall health. Scientific research continues to reveal the connection between microbiome imbalances and disease, driving demand for microbiome-based solutions. Additionally, regulatory policies and consumer preferences are shifting toward reducing antibiotic use in animal care, promoting the adoption of natural alternatives like probiotics and postbiotics for disease prevention.
Moreover, advances in microbiome research have also paved the way for customized diets and functional feeds tailored to an animal’s microbiome profile, significantly improving health and performance. As a result, startups and major pet food companies are investing in microbiome-enhancing nutrition, further advancing this rapidly growing field. In January 2024, Novozymes acquired Microbiome Labs, an Illinois-based company specializing in probiotic and microbiome solutions for consumer health. This acquisition strengthened Novozymes’ position in the microbiome industry, expanding its portfolio of innovative probiotic solutions. The gut microbiome plays a crucial role in breaking down food, absorbing nutrients, and producing essential vitamins, contributing to overall digestive health. Beneficial bacteria help maintain a balanced digestive system, preventing issues such as diarrhea, constipation, and bloating.
Additionally, a healthy microbiome supports skin health by reducing inflammation and allergic reactions, as imbalances can lead to conditions like itchy skin, hot spots, or chronic ear infections in pets. In the same month, Kemin Industries launched Enterosure, a probiotic solution designed to control pathogenic bacterial growth in poultry and livestock. This innovative product promotes a healthy microbiome, enhances intestinal resilience, manages gut health challenges, and ultimately improves animal productivity. These developments highlight the increasing importance of microbiome-based solutions in both companion animals and livestock, driving advancements in animal health and nutrition.
Competitive Landscape
Some of the Major Key Players in the Veterinary Microbiome Market are
• Adisseo
• Alltech
• AnimalBiome
• BaseClear BV
• Biorigin
• CanBiocin
• Cargill, Incorporated
• Chr. Hansen Holding A/S
• Cytophage Technologies Ltd
• DSM
• Evonik Industries AG
• Hill's Pet Nutrition, Inc.
• Kemin Industries Inc
• Lallemand Inc.
• Land O'Lakes
• Leiber
• MicroSintesis Inc.
• NomNomNow Inc.
• Novozymes
• Novus International, Inc.
• Orion Corporation
• Pando Nutrition Inc.
• Petivity
• PhageLab
• Phibro Animal Health Corporation
• Phileo (Lesaffre)
• Porcinotec Co., Ltd.
• Proteon Pharmaceuticals S.A.
Market Segmentation
The veterinary microbiome market is segmented based on the by-product, application and, animal type. Based on the product, the market is divided into phage therapy products, functional food applications, gut health test kits, microbial proteins, and others. Based on the Application, the market is divided into pathogen control, microbiome analysis, and nutrition. Based on the animal type, the market is divided into companion animals, poultry, ruminants, swine, aquaculture, and others. Based on the Companion animals, the segment is divided into dogs and cats.
The Functional Food Segment is Expected to Have the Highest Growth Rate During the Forecast Period
Based on the product, the market is divided into phage therapy products, functional food applications, gut health test kits, microbial proteins, and others. Among these, the functional food segment is expected to have the highest growth rate during the forecast period. The functional food segment is divided into probiotics, prebiotics, and postbiotics. Pet owners and livestock producers increasingly recognize the gut microbiome's vital role in digestion, immunity, and overall health. Scientific studies link microbiome imbalances to various diseases, driving demand for functional foods that support gut health. Growing concerns over antibiotic resistance have led to regulatory changes and consumer pressure to reduce antibiotic use in animal feed. As a natural alternative, probiotics and prebiotics help promote beneficial gut bacteria and prevent infections without relying on antibiotics. With a rising preference for natural, non-pharmaceutical solutions, functional foods offer preventive care, minimizing the need for medications and veterinary interventions.
The Poultry Segment Dominates the Market
Based on the animal type, the market is divided into companion animals, poultry, ruminants, swine, aquaculture, and others. Based on the Companion animals, the segment is divided into dogs and cats. Among these, the poultry segment dominates the market. Poultry is one of the most widely consumed meats worldwide, creating a strong demand for sustainable and efficient production. A healthy microbiome plays a crucial role in enhancing growth rates, improving feed conversion efficiency, and boosting overall productivity, making microbiome solutions essential for the poultry industry. To support gut health and disease prevention, poultry producers are increasingly incorporating probiotics, prebiotics, and postbiotics into feed formulations. These microbiome-enhancing additives help strengthen gut integrity, reduce pathogenic bacteria, and optimize bird performance. Additionally, companies and research institutions are investing in the development of species-specific probiotics and microbiome-based vaccines, further advancing poultry health and production efficiency.
Asia Pacific Has the Largest Market Share During the Forecast Period.
The Asia-Pacific region dominates the veterinary microbiome market due to its large livestock and poultry population, increasing meat consumption, rising demand for antibiotic-free animal products, and advancements in microbiome research and biotechnology. Rising pet ownership in urban areas of China, Japan, India, and South Korea is increasing the demand for microbiome-based pet food, probiotics, and digestive health solutions. Pet food companies in Asia-Pacific are incorporating microbiome-enhancing ingredients to cater to health-conscious pet owners. Major animal health companies and biotech firms are expanding their presence in Asia-Pacific to tap into the growing microbiome market.
Recent Developments:
• In October 2024, Lesaffre performed the acquisition of a majority stake in Biorigin, a business unit of Zilor, a multinational company producing yeast derivative products, to enhance the supply of yeast derivatives for savory ingredients. The cooperation will improve production processes, logistics, and services to the benefit of a global customer base.
• In Sept 2023, CareVet, a prominent network of veterinary hospitals, collaborated with Blendvet and Hill's Pet Nutrition to incorporate diversity, equity, inclusion, and belonging (DEIB) content into its comprehensive Learning Management System, CareVet Learning Institute. This innovative effort sought to enhance workplace environments by promoting inclusivity and a sense of belonging for teams, clients, and the community.
Veterinary Microbiome Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 6,885.40 Bn |
|
Revenue Forecast In 2034 |
USD 12,060.52 Bn |
|
Growth Rate CAGR |
CAGR of 5.4 % from 2024 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2024-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Application, Animal Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Adisseo, Alltech, AnimalBiome, BaseClear BV, Biorigin, CanBiocin, Cargill, Incorporated, Chr. Hansen Holding A/S, Cytophage Technologies Ltd, DSM, Evonik Industries AG, Hill's Pet Nutrition, Inc., Kemin Industries Inc, Lallemand Inc., Land O'Lakes, Leiber, MicroSintesis Inc., NomNomNow Inc., Novozymes, Novus International, Inc., Orion Corporation, Pando Nutrition Inc., Petivity, PhageLab, Phibro Animal Health Corporation, Phileo (Lesaffre), Porcinotec Co., Ltd., Proteon Pharmaceuticals S.A. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
